Our results showed that the effect of melatonin on the expression of this gene is dose-dependent, in a way that Gdf9 is transcribed in PCOS oocytes at high concentrations of melatonin (10–5 M) and significantly decreases with the reduction of melatonin concentration. Here, GDF9 is linked to polycystic ovary syndrome.